H.C. Wainwright analyst Yi Chen initiated coverage of VolitionRx (VNRX) with a Buy rating and $2.50 price target VolitionRx is a diagnostics company focused on the development of epigenetic tests ...

Below is ticketing information for our Premier League fixture against Liverpool at Anfield on Sunday, May 11 at 16:30 pm. We have received an allocation of 3,052 tickets for this fixture, which will ...

The latest price target for Akebia Therapeutics (NASDAQ:AKBA) was reported by HC Wainwright & Co. on April 4, 2025. The analyst firm set a price target for $7.50 expecting AKBA to rise to within ...

Bill Callahan at Assembly, Samara Joy at Bardavon, Martha Wainwright at Levon Helm, and a host of experimental and world music Bill Callahan. Every month, we’re curating a list of bands and ...

We are delighted to announce that Andrea Berta is joining the club as Sporting Director. Andrea is a hugely respected figure in football and brings with him a wealth of knowledge and experience. He ...

The latest price target for Femasys (NASDAQ:FEMY) was reported by HC Wainwright & Co. on March 28, 2025. The analyst firm set a price target for $15.00 expecting FEMY to rise to within 12 months ...

HRLS Partners – comprised of Robert Hryniewicki, Adam Rackliffe, Christopher Leary, and Micah Smith – successfully closed nearly 1,300 transactions throughout their careers, spanning a ...

H.C. Wainwright analyst Edward White reiterated a Buy rating on Valneva (VALN – Research Report) today and set a price target of $17.00. The company’s shares closed yesterday at $7.43.

RE/MAX Success Realty is proud to announce the appointment of Ray Dubash as its new Chief Executive Officer (CEO). I am thrilled to join RE/MAX Success Realty at a dynamic time in the industry.

Knowing the rules for capital gains tax on residential real estate and home sales is important, especially since your property has likely increased in value since you purchased it. Eventually ...